Do you want to read an article? Please log in or register.
Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement
Lancet Gastroenterol Hepatol
Alexander JL, Moran GW, Gaya DR, Raine T, Hart A, Kennedy NA, Lindsay JO, MacDonald J, Segal JP, Sebastian S, Selinger CP, Parkes M, Smith PJ, Dhar A, Subramanian S, Arasaradnam R, Lamb CA, Ahmad T, Lees CW, Dobson L, Wakeman R, Iqbal TH, Arnott I, Powell N, Inflammatory Bowel Disease section of the British Society of Gastroenterology and the the Inflammatory Bowel Disease Clinical Research Group.
doi: 10.1016/S2468-1253(21)00024-8
Inflammatory Bowel Disease
T cell response after SARS-CoV-2 vaccination in immunocompromised patients with inflammatory bowel disease
J Crohns Colitis
Reuken PA, Andreas N, Grunert PC, Glöckner S, Kamradt T, Stallmach A
doi: 10.1093/ecco-jcc/jjab147
HepatitisInflammatory Bowel Disease
Vaccination rate and immunity of children and adolescents with inflammatory bowel disease or autoimmune hepatitis in Germany
Vaccine.
Luana C, Teresa S, Sarah E, Klara F, Andreas K, Elke L, Patrick G, Henning L, Jan V, Michael R, Stefan T, Benjamin M, Sibylle K, Klaus-Michael D, Thomas M, Carsten P
doi: 10.1016/j.vaccine.2019.12.024.
Inflammatory Bowel Disease
Improved Antibody Response to Three Additional Hepatitis B Vaccine Doses Following Primary Vaccination Failure in Patients with Inflammatory Bowel Disease
Dig Dis Sci.
Pratt PK Jr, Nunes D, Long MT, Farraye FA
doi: 10.1007/s10620-
Further Publications
Effectiveness of SARS-CoV-2 vaccination in a Veterans Affairs Cohort of Inflammatory Bowel Disease Patients with Diverse Exposure to Immunosuppressive Medications
Gastroenterology
Khan N, Mahmud N
doi: 10.1053/j.gastro.2021.05.044
Inflammatory Bowel Disease
Adverse Events Following SARS-CoV-2 mRNA Vaccination: Among Patients with Inflammatory Bowel Disease
Am J Gastroenterol
Botwin GJ, Li D, Figueiredo J, Cheng S, Braun J, McGovern DPB, Melmed GY
doi: 10.14309/ajg.0000000000001342
Inflammatory Bowel Disease
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre
United European Gastroenterol J.
Scaldaferri F, Pugliese D, Privitera G, Onali S, Lopetuso LR, Rizzatti G, Settanni CR, Pizzoferrato M, Schiavoni E, Turchini L, Amatucci V, Napolitano D, Bernabei T, Mora V, Laterza L, Papa A, Guidi L, Rapaccini GL, Gasbarrini A, Armuzzi A
doi: 10.1177/2050640620929133.
Inflammatory Bowel Disease
Inflammatory Bowel Diseases and Biological Treatment in SARS-CoV-2 Era. Why Not?
Inflamm Bowel Dis.
Grassia R, Soro S, Conti CB
doi: 10.1093/ibd/izaa110.
COMMENTED
Inflammatory Bowel Disease
SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting
★ 3
Recommended and commented by
PD Dr Luc Biedermann, Faculty Member
Gut
Siegel CA, Melmed GY, McGovern DP, Rai V, Krammer F, Rubin DT, Abreu MT, Dubinsky MC, International Organization for the Study of Inflammatory Bowel Disease (IOIBD)., International Organization for the Study of Inflammatory Bowel Diseases (IOIBD).
doi: 10.1136/gutjnl-2020-324000